InvestorsHub Logo
Followers 84
Posts 12534
Boards Moderated 0
Alias Born 07/25/2008

Re: None

Wednesday, 03/04/2015 7:53:03 PM

Wednesday, March 04, 2015 7:53:03 PM

Post# of 3205
Barclays Expands Coverge To 7 New Biotechs

Enanta Pharmaceuticals Inc (NASDAQ: ENTA) was rated at Equal-weight with a $35 price target. The firm forecasted "peak WW Viekira Pak sales of $2.5B and see limited room for upside given increasing competition in hep C."

What does Barclays know after all...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News